A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug-resistant epilepsy.

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Kwan, Patrick (Chief Investigator (CI))
  • D'Souza, Wendyl (Chief Investigator (CI))
  • Berkovic, Samuel F (Chief Investigator (CI))
  • Carney, Patrick (Chief Investigator (CI))
  • Nikpour, Armin (Chief Investigator (CI))
  • Reutens, David C. (Chief Investigator (CI))
  • Frasca, Joseph (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date10/10/1931/12/21

Keywords

  • Neurology
  • Epilepsy
  • Clinical trial